Matches in Wikidata for { <http://www.wikidata.org/entity/Q91993245> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q91993245 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91993245 description "scientific article published on 17 April 2020" @default.
- Q91993245 description "wetenschappelijk artikel" @default.
- Q91993245 description "наукова стаття, опублікована 17 квітня 2020" @default.
- Q91993245 name "Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12" @default.
- Q91993245 name "Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12" @default.
- Q91993245 type Item @default.
- Q91993245 label "Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12" @default.
- Q91993245 label "Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12" @default.
- Q91993245 prefLabel "Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12" @default.
- Q91993245 prefLabel "Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12" @default.
- Q91993245 P1433 Q91993245-1AB39198-32C9-4F93-B441-C5374080B164 @default.
- Q91993245 P1476 Q91993245-AC7D37A4-63CF-4370-9DD4-DE41A69D1AA5 @default.
- Q91993245 P2093 Q91993245-15AFF050-9692-4844-A4C7-4C989C10ECF2 @default.
- Q91993245 P2093 Q91993245-2A795F0D-3A97-464D-9F46-FEBA77AE9C96 @default.
- Q91993245 P2093 Q91993245-48D050CF-4BE0-4596-AFE1-B8F28A7B0BF5 @default.
- Q91993245 P2093 Q91993245-755F697E-0486-45FF-B10B-B2380EAC54DC @default.
- Q91993245 P2093 Q91993245-98E8D318-037E-4EBB-96E6-8039F31FA3F2 @default.
- Q91993245 P2093 Q91993245-B85D759A-8AE2-4250-94B3-68323E6F4BFD @default.
- Q91993245 P275 Q91993245-EB18636F-A85E-4761-ACC6-37A5AC0CE41A @default.
- Q91993245 P304 Q91993245-CC8AFAEB-1F08-4E51-9F5F-BAA00731A77E @default.
- Q91993245 P31 Q91993245-B35009E4-A0CD-4B9E-91D7-A8D41F38A730 @default.
- Q91993245 P356 Q91993245-7167196F-7343-4FE3-9BC4-454ADFF8BDCB @default.
- Q91993245 P50 Q91993245-E8F2B018-AF98-45E0-B96C-F2C78C7AB597 @default.
- Q91993245 P50 Q91993245-FE86C851-F889-49A6-B154-E20039EDA2DD @default.
- Q91993245 P577 Q91993245-CBAC86FD-D504-4B7F-8A62-AA2038D75B57 @default.
- Q91993245 P6216 Q91993245-B6287D60-1A97-4583-A2DC-E240708E44DD @default.
- Q91993245 P698 Q91993245-E5DDC254-2948-457F-A574-9E63369E76F8 @default.
- Q91993245 P921 Q91993245-60A7C8A2-4F72-4FD0-A1CC-D27465812504 @default.
- Q91993245 P356 09546634.2020.1747592 @default.
- Q91993245 P698 32299269 @default.
- Q91993245 P1433 Q6295084 @default.
- Q91993245 P1476 "Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12" @default.
- Q91993245 P2093 "Alice B Gottlieb" @default.
- Q91993245 P2093 "Christopher Schuster" @default.
- Q91993245 P2093 "Daniel Saure" @default.
- Q91993245 P2093 "Diamant Thaçi" @default.
- Q91993245 P2093 "Martin Dossenbach" @default.
- Q91993245 P2093 "Stefan Wilhelm" @default.
- Q91993245 P275 Q24082749 @default.
- Q91993245 P304 "1-8" @default.
- Q91993245 P31 Q13442814 @default.
- Q91993245 P356 "10.1080/09546634.2020.1747592" @default.
- Q91993245 P50 Q48357623 @default.
- Q91993245 P50 Q86141743 @default.
- Q91993245 P577 "2020-04-17T00:00:00Z" @default.
- Q91993245 P6216 Q50423863 @default.
- Q91993245 P698 "32299269" @default.
- Q91993245 P921 Q10355321 @default.